XML 36 R24.htm IDEA: XBRL DOCUMENT v3.25.2
SEGMENT REPORTING
 6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
SEGMENT REPORTING SEGMENT REPORTING
The Company has adopted ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures and has revised prior year disclosures to conform with the current year presentation. The Company operates as a single reportable segment, infusion services. Infusion services derives revenue through the clinical management of infusion therapy, nursing support and care coordination in order to provide solutions to complex patient conditions in the home or other nonhospital settings. The Company’s infusion services segment activities are managed on a consolidated basis and therapies are distributed and administered in a similar manner.
Operating segments have been identified based on the financial information utilized by the Company’s Chief Executive Officer, the chief operating decision maker (“CODM”). The CODM uses net income as a measure of profitability to assess segment performance and deciding how to allocate resources such as capital investments, share repurchases, and acquisitions. The CODM does not use or receive total assets by segment to make decisions regarding resources; therefore, the total asset disclosure by segment has not been included.
The following table reflects results of operations of the Company’s reportable segment (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Infusion services net revenue$1,393,008 $1,205,561 $2,704,189 $2,331,223 
Other revenue (1)23,077 21,625 44,868 42,015 
Total Option Care Health revenue1,416,085 1,227,186 2,749,057 2,373,238 
(Expense) Income:
Cost of net revenues - drugs(1,004,610)(847,420)(1,937,678)(1,624,680)
Salaries, benefits, and other employee expense(212,195)(193,298)(417,887)(385,113)
Other segment items (2)(100,329)(90,886)(199,607)(184,105)
Depreciation and amortization expense(16,241)(14,907)(31,987)(29,635)
Interest expense, net(14,447)(12,603)(27,678)(25,805)
Equity in earnings of joint ventures1,395 1,405 3,124 2,530 
Other, net(797)2,564 (4,927)2,566 
Income tax expense(18,338)(18,998)(35,152)(31,162)
Net Income$50,523 $53,043 $97,265 $97,834 
(1) Represents business activities related to other miscellaneous revenue streams.
(2) Other segment items includes expenses for medical supplies, delivery and packaging, leases, professional services, and other expenses.